You are here

Drug Forecast

Erlotinib (Tarceva®): A Brief Overview

Donna Clay, RPh, Yvette M. Lipman, PharmD, and Mary Ellen Bonk, PharmD
PDF version: 
The authors review erlotinib (Tarceva®) for the treatment of non–small-cell lung cancer.